CTRI/2024/01/061651尚未招募Unknown
Cancer stem cell marker CD133 in Triple Negative Breast Cancer versus Non-Triple Negative Breast Cancer– An immunohistochemical study. - NI
试验速览
- 阶段
- Unknown
- 状态
- 尚未招募
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
入选标准
- •Histopathologically confirmed cases of Infiltrating Ductal Carcinoma (no special type NST)
排除标准
- •Patients with prior neoadjuvant chemotherapy or radiation therapy
研究者
相似试验
招募中
不适用
A pilot study of the role of CD133+ as a cell marker for human haematopoietic stem cellsStem cell transplantationBlood - Haematological diseasesCancer - MyelomaACTRN12609000590268aunceston General Hospital, Pathology Department40
进行中（未招募）
1 期
CD133 + CELL INFUSION IN PATIENTS WITH COLORECTAL LIVER ORIGIN METASTASES GOING TO BE SUBMITTED TO A MAJOR LIVER RESECTIOEUCTR2014-001402-18-ESALEJANDRA GARCIA BOTELLA4
已完成
不适用
AFP - L3% and DCP as tumor markers in patients with hepatocellular carcinoma (HCC) treated with transarterial chemoembolisation (TACE)C22.0Liver cell carcinomaDRKS00000812KL Freiburg, Med. Klinik II85
已完成
不适用
Circulating tumor cells as a diagnostic marker for pancreatico-biliary malignanciesPancreatico-biliary malignanciesJPRN-UMIN000029808Fukushima Medical University School of Medicine22
尚未招募
不适用
Molecular diagnostics of brain tumors using third-generation sequencingC70C71C72Malignant neoplasm of meningesMalignant neoplasm of brainMalignant neoplasm of spinal cord, cranial nerves and other parts of central nervous systembrain tumorDRKS00018102Charité Campus Charité Mitte211